Healthcare Equipment and Supplies
Company Overview of Soleno Therapeutics, Inc.
Key Executives for Soleno Therapeutics, Inc.
|Anish Bhatnagar M.D.||14 Relationships||Chief Executive Officer, President and Director||46|
|David D. O'Toole||No Relationships||Chief Financial Officer and Senior Vice President||57|
|Anthony Wondka||No Relationships||Senior Vice President of Research and Development||54|
|Otho Boone||No Relationships||Vice President and General Manager of Neonatology||--|
|Kristen Yen||No Relationships||Vice President of Clinical and Regulatory Affairs||--|
Soleno Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Ernest Mario Ph.D.||264 Relationships||Apothogen, Inc.||77|
|Anish Bhatnagar M.D.||14 Relationships||Soleno Therapeutics, Inc.||46|
|Steinar J. Engelsen M.D., M.Sc., CEFA.||35 Relationships||Teknoinvest AS||65|
|Stephen Kirnon Ed.D.||14 Relationships||Strawn Arnold Ashpitz Groover, Ltd.||53|
|William G. Harris||14 Relationships||Xenoport, Inc.||58|
Soleno Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||William G. Harris||14 Relationships||3 Executives|
|Compensation Committee M.D., M.Sc., CEFA.||Steinar J. Engelsen||35 Relationships||4 Executives|
|Nominating Committee Ed.D.||Stephen Kirnon||14 Relationships||4 Executives|
|Corporate Governance Committee Ed.D.||Stephen Kirnon||14 Relationships||4 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$460.0K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.